masterclass: evidence on the use of sglt2is in hf across the ef spectrum
Published 2 years ago • 185 plays • Length 29:38Download video MP4
Download video MP3
Similar videos
-
5:02
esc 2022: emperor-preserved & deliver meta-analysis: sglt2is in heart failure | dr vaduganathan
-
4:45
esc 2022: the emperor-pooled trial: clinical benefits of sglt2i in heart failure | dr faiez zannad
-
8:15
sglt2 inhibitors and heart failure
-
19:19
therapy for heart failure w/ reduced ejection fraction - when & how to introduce sglt2 inhibitors
-
9:38
top 7 heart failure treatments proven to improve outcomes
-
5:59
heart failure and 6 tips for exercising with it
-
18:12
heart failure - enter the emperor
-
29:16
the implications of the latest data on sglt2 inhibitors in heart failure: a unified approach to t...
-
13:17
empagliflozin in heart failure with a preserved ejection fraction
-
20:09
esc 2021 discussion: the emperor-pooled study | dr harriette van spall & dr milton packer
-
10:57
best practices for starting sglt2 inhibitors in hfpef treatment
-
4:20
safety and efficacy of using insulin-like growth factor-1 in heart attack
-
12:49
esc tv conversations - sglt2 inhibitors – wonder drugs in heart failure and beyond?
-
20:13
sglt2 inhibitors in heart failure management with dr. john mcmurray
-
34:54
professor stephen wiviott - 'sglt2 outcome trials - an evolving story'
-
2:56
esc 2022: the emmy trial: empagliflozin in patients with acute mi | prof harald sourji
-
7:56
hfsa 22: heart failure recognition with micro electro-mechanical sensors | dr juuso blomster
-
4:16
cholangiography: new techniques are best
-
30:31
dissecting the heart | dr stephanie armstrong, senior lecturer in health quality improvement